Ausgabe 1/2005
Inhalt (11 Artikel)
The health insurance industry should cover the evaluation and treatment of sexual dysfunction
Myron I. Murdock
Penile revascularization remains a viable option in the era of oral pharmacotherapy: Pro
Yoram Vardi, Ilan Gruenwald
Penile revascularization remains a viable option in the era of oral pharmacotherapy: Con
Eli F. Lizza
Behavioral and psychologic models in ejaculatory function research
David L. Rowland, Stewart E. Cooper
Controversies regarding testosterone supplementation in the prostate cancer patient
Jeffrey P. Bejma, Dena Walsh, Muammer Kendirci, Wayne J. G. Hellstrom